Atherosclerosis
Volume 211, Issue 1 , Pages 242-248 , July 2010

Cytokines release inhibition from activated monocytes, and reduction of in-stent neointimal growth in humans

  • Gabriele Pesarini

      Affiliations

    • Department of Biomedical Sciences and Surgery, University of Verona, Division of Cardiology, Verona, Italy
    • ,
  • Angela Amoruso

      Affiliations

    • Department of Medical Sciences, University of Piemonte Orientale “A. Avogadro”, Novara, Italy
    • ,
  • Valeria Ferrero

      Affiliations

    • Department of Biomedical Sciences and Surgery, University of Verona, Division of Cardiology, Verona, Italy
    • ,
  • Claudio Bardelli

      Affiliations

    • Department of Medical Sciences, University of Piemonte Orientale “A. Avogadro”, Novara, Italy
    • ,
  • Luigia Grazia Fresu

      Affiliations

    • Department of Medical Sciences, University of Piemonte Orientale “A. Avogadro”, Novara, Italy
    • ,
  • Laura Perobelli

      Affiliations

    • Laboratory of Clinical Biochemistry and Haematology of the Ospedale Civile Maggiore, Verona, Italy
    • ,
  • Paolo Scappini

      Affiliations

    • Laboratory of Clinical Biochemistry and Haematology of the Ospedale Civile Maggiore, Verona, Italy
    • ,
  • Giuseppe De Luca

      Affiliations

    • Department of Medical Sciences, University of Piemonte Orientale “A. Avogadro”, Novara, Italy
    • ,
  • Sandra Brunelleschi

      Affiliations

    • Department of Medical Sciences, University of Piemonte Orientale “A. Avogadro”, Novara, Italy
    • ,
  • Corrado Vassanelli

      Affiliations

    • Department of Biomedical Sciences and Surgery, University of Verona, Division of Cardiology, Verona, Italy
    • ,
  • Flavio Ribichini

      Affiliations

    • Department of Biomedical Sciences and Surgery, University of Verona, Division of Cardiology, Verona, Italy
    • Corresponding Author InformationCorresponding author at: Catheterization Laboratory of the University of Verona, Ospedale Civile Maggiore, Piazzale A. Stefani 1, 37126, Verona, Italy. Tel.: +39 045 812 2039; fax: +39 045 802 7307.

Received 14 June 2009 ,Revised 19 January 2010 ,Accepted 1 February 2010.

References 

  1. Welt FG, Rogers C. Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol. 2002;22:1769–1776
  2. Fukuda D, Shimada K, Tanaka A, et al. Circulating monocytes and in-stent neointima after coronary stent implantation. J Am Coll Cardiol. 2004;43:18–23
  3. Liuzzo G, Santamaria M, Biasucci LM, et al. Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein. Evidence for a direct proinflammatory effect of azide and lipopolysaccharide-free C-reactive protein on human monocytes via nuclear factor kappa-B activation. J Am Coll Cardiol. 2007;49:185–194
  4. Libby P. Act local, act global, inflammation and the multiplicity of vulnerable coronary plaques. J Am Coll Cardiol. 2005;45:1600–1602
  5. Ribichini F, Joner M, Ferrero V, et al. Effects of oral prednisone after stenting in a rabbit model of established atherosclerosis. J Am Coll Cardiol. 2007;50:176–185
  6. Versaci F, Gaspardone A, Tomai F, et al. Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS Study). J Am Coll Cardiol. 2002;40:1935–1942
  7. Ribichini F, Tomai F, Ferrero V, et al. Immunosuppressive oral prednisone after percutaneous interventions in patients with multi-vessel coronary artery disease. The IMPRESS-2/MVD study. Eurointervention. 2005;2:173–180
  8. Ferrero V, Ribichini F, Pesarini G, et al. Therapeutic potential of glucocorticoids in the prevention of restenosis after coronary angioplasty. Drugs. 2007;67:1243–1255
  9. Almawi WY, Melemedjian OK. Molecular mechanisms of glucocorticoids antiproliferative effects: antagonism of transcription factor activity by glucocorticoids receptor. J Leukoc Biol. 2002;71:9–15
  10. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-Kappa B activity through induction of I Kappa B synthesis. Science. 1995;270:286–290
  11. Ribichini F, Tomai F, De Luca G, et al. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES)—study design and rationale. J Cardiovasc Med. 2009;10:192–199
  12. Amoruso A, Bardelli C, Gunella G, Ribichini F, Brunelleschi S. A novel activity for substance P: stimulation of peroxisome proliferator-activated receptor-γ in human monocytes and macrophages. Br J Pharmacol. 2008;154:144–152
  13. Lavagno L, Gunella G, Bardelli C, et al. Anti-inflammatory drugs and tumor necrosis factor-α production from monocytes: role of transcription factor NF-kB and implication for rheumatoid arthritis therapy. Eur J Pharmacol. 2004;501:199–208
  14. Gai MN, Pinilla E, Paulos C, Chavez J, Puelles V, Arancibia A. Determination of prednisolone and prednisone in plasma, whole blood, urine and bound to plasma proteins by high-preformance liquid chromatography. J Chromatogr Sci. 2005;43:201–206
  15. Ferry JJ, Horvath AM, Bekersky I, Heath EC, Ryan CF, Colburn WA. Relative and absolute bioavailability of prednisone and prednisolone after separate oral and intravenous doses. J Clin Pharmacol. 1988;28:81–87
  16. Liuzzo G, Buffon A, Biasucci LM, et al. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation. 1998;98:2370–2376
  17. Hojo Y, Ikeda U, Katsuki T, et al. Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis. Heart. 2000;84:83–87
  18. Szkodzinski J, Blazelonis A, Wilczek K, et al. The role of interleukin-6 and transforming growth factor-beta1 in predicting restenosis within stented infarct-related artery. Int J Immunopathol Pharmacol. 2009;22:493–500
  19. Murayama H, Takahashi M, Takamoto , et al. Deficiency of tumour necrosis factor-alpha and interferon-gamma in bone marrow cells synergistically inhibits neointimal formation following vascular injury. Cardiovasc Res. 2008;80:175–180
  20. Ferrero V, Tomai F, Versaci F, et al. Long-term results of immunosuppressive oral prednisone after coronary angioplasty in non-diabetic patients with elevated C-reactive protein levels. Eurointervention. 2009;5:250–254
  21. Brunelleschi S, Bardelli C, Amoruso A, et al. Minor polar compounds in extra-virgin olive oil extract (MPC-OOE) inhibits NF-κB translocation in human monocyte/macrophages. Pharmacol Res. 2007;56:542–549

PII: S0021-9150(10)00102-4

doi: 10.1016/j.atherosclerosis.2010.02.004

Atherosclerosis
Volume 211, Issue 1 , Pages 242-248 , July 2010

Article Tools

* Image Usage & Resolution